Author:
Lin T S,Flinn I W,Lucas M S,Porcu P,Sickler J,Moran M E,Lucas D M,Heerema N A,Grever M R,Byrd J C
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference8 articles.
1. Hale G, Bright S, Chumbley G, Hoang T, Metcalf D, Munro AJ et al. Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement. Blood 1983; 62: 873–882.
2. Flynn JM, Byrd JC . Campath-1H monoclonal antibody therapy. Curr Opin Oncol 2000; 12: 574–581.
3. Keating MJ, Flinn I, Jain V, Binet J-L, Hillmen P, Byrd JC et al. Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study. Blood 2002; 99: 3554–3561.
4. Mazzulli T, Drew LW, Yen-Lieberman B, Jekic-McMullen D, Kohn DJ, Isada C et al. Multicenter comparison of the digene hybrid capture CMV DNA assay (version 2.0), the pp65 antigenemia assay, and cell culture for detection of cytomegalovirus viremia. J Clin Microbiol 1999; 37: 958–963.
5. Byrd JC, Smith L, Hackbarth ML, Flinn IW, Young D, Proffitt JH et al. Interphase cytogenetic abnormalities in chronic lymphocytic leukemia may predict response to rituximab. Cancer Res 2003; 63: 36–38.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献